A quality study to improve prophylactic antithrombotic therapy prescribed to patients with atrial fibrillation;Um estudo de qualidade numa unidade de saúde familiar para a melhoria da qualidade da terapêutica profilática antitrombótica prescrita a doentes com fibrilhação auricular

Revista Portuguesa de Cardiologia

Volumn 33, Issue 2, 2014, Pages 89-94

  Oliveira, Rui ^a   Grilo, Sandra ^a   Moreira, Carla ^a   Santos, Jorge ^a   Feitor, Rodolfo ^b   Moreira, Raquel ^a   Rocha, Martina ^a  

^a USF Infante D Henrique   (Portugal)

^b UCSP D Duarte   (Portugal)

Author keywords

Atrial fibrillation; Bleeding risk score; CHA2DS2 VASc; Thromboembolic risk stratification

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

ANTICOAGULANT THERAPY; ARTICLE; FAMILY HEALTH; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PROPHYLAXIS; RISK ASSESSMENT; AGED; ATRIAL FIBRILLATION; COMPLICATION; EVALUATION STUDY; FEMALE; MALE; THROMBOSIS; TOTAL QUALITY MANAGEMENT;

AGED; ATRIAL FIBRILLATION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; QUALITY IMPROVEMENT; THROMBOSIS;

EID: 84898771860     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repc.2013.04.018     Document Type: Article

References (15)

1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagula-tion and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-5.
2. Snow V, Weiss KB, LeFevre M, et al. Management of newly detected atrial fibrillation: A clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med. 2003;139: 1009-17.
3. Camm AJ, Kirchhof P Lip GY, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369-429.
4. Guize L, Thomas FBean K, et al. Atrial fibrillation: Prevalence, risk factors and mortality in a large French population with 15 years of follow-up. Bull Acad Natl Med. 2007;191:791-803, discussion-5.
5. Murphy NF, Simpson CR, Jhund PS, et al. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart. 2007;93:606-12.
6. Bonhorst D, Mendes M, Adragao Pet al. Prevalence of atrial fibrillation in the Portuguese population aged 40 and over: The FAMA study. Rev Port Cardiol. 2010;29:331-50.
7. Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271:840-4.
8. Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995;155:469-73.
9. Pedersen OD, Abildstrom SZ, Ottesen MM, et al. Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction. Eur Heart J. 2006;27:290-5.
10. Risk factors for stroke and efficacy of antithrombotic therapy in atrial, fibrillation. Analysis of pooled data from five randomized controlled, trials. Arch Intern Med. 1994;154:1449-57.
11. Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey. Chest. 2010;138:1093-100.
12. World Organizations of National Colleges, Academies, Academic Associations of General Practitioners/Family Physicians (WONCA). ICPC-2: International Classification of Primary Care. Oxford, NY: Oxford University Press; 1998.
13. Ascensao P. Fibrilhaccao auricular e prevenccao do tromboembo-lismo. Estudo numa populacao de utentes de Centros de Saude. Rev Port Clin Geral. 2006;22:12.
14. Sa MC, Balsa MJ. Anticoagulacao oral nos muito idosos e seus determinantes clinicos. Rev Port Med Geral Fam. 2012;28:9.
15. Camm AJ, Lip GY, de Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Eur Heart J. 2012;33:2719-47.